Monomer Bio offers an AI-ready lab automation and analytics platform that integrates robotic automation, data management, computer vision, and deep learning to digitize lab workflows and accelerate drug discovery. The platform can detect significant changes in cell morphology from microscopy images and supports larger-scale, more complex experiments. It is compatible with lab equipment from major manufacturers and provides an intuitive interface for customized automation workflows; the team also helps customers optimize their lab setups. Customers such as Indee Labs have used Monomer’s software to increase cell production. Founded by CEO Jimmy Sastra and CTO Mark Zhang, the company aims to simplify data management, analytics, and automation for scientists and eliminate manual bottlenecks. Monomer announced a $5.6M seed raise to fund expansion and further enhance its platform to empower more laboratories and researchers.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2024